HIGHLIGHTS
- who: Katharina S. Schmitz and collaborators from the College of Medicine Viroscience, Erasmus MC, Rotterdam, the Netherlands Columbia University have published the research: Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern, in the Journal: (JOURNAL) of 24/08/2022
- future: In future studies the authors will use infections in the human airway epithelial (HAE) model as well as animal models to study the potential for emergence of SARS-CoV-2 viruses resistant to the inhibitory effect of the peptides after longer periods of treatment or repeated courses as the authors have . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.